Merck & Co. has received a positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to expand ...

Merck & Co. announced today that its groundbreaking cancer drug, Keytruda, has reached a major milestone in its late-stage clinical trial for the ...